Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtech Tools To Help Address Opioid Crisis Face Reimbursement Challenges

Executive Summary

A wide variety of devices that could either serve as pain-relief substitutes for opioids, help manage opioid addictions or tackle distribution issues with the overly prescribed medications are facing reimbursement challenges at the US Centers for Medicare and Medicaid Services.

Advertisement

Related Content

Pendulum To Swing To More Congressional Oversight Of FDA Device Regs, Hill Experts Say
Senate Passes 'Minibus' Appropriations Bill Increasing NIH Funds And Directing CMS Program Funding
Bills Supporting Device Opioid Alternatives Advance In House
Advancing Bill Would Require Medicare Plans To Highlight Device Opioid Alternatives
CMS Could Increase Access To Non-Pharmacological Pain Treatments, US Congress Report Says
Nonprofit Pharma Targets Making Naloxone Available OTC, Trimming Price
Neurostimulator Is First Device Marketed To Reduce Opioid Withdrawal Symptoms
Opioid Use Disorder App Marks A Path For 510(k) 'Breakthrough' Devices
'Excellence' In Health-Software Design: US FDA Taps Nine Firms To Figure Out What That Means
CMS Makes Policy Waves With Pullback Of Longstanding TENS Coverage

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT122307

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel